查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1844120

定序試劑市場按產品類型、應用、技術、最終用戶和平台分類－2025-2032年全球預測

Sequencing Reagents Market by Product Type, Application, Technology, End User, Platform - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，定序試劑市場規模將達到 128 億美元，複合年成長率為 10.93%。

主要市場統計數據
基準年 2024 55.8億美元
預計年份：2025年 62億美元
預測年份：2032年 128億美元
複合年成長率 (%) 10.93%

簡要說明定序試劑市場格局，重點在於技術差異、採購現況和平台主導的供應商動態。

定序試劑產業處於分子生物學創新與下游應用（包括診斷、治療發現和環境基因組學）的關鍵交匯點。讀取長度、通量和化學技術的進步正推動試劑需求從通用組分轉向高度專業化、平台最佳化的配方。這種演變造就了充滿活力的供應商格局，其中試劑品質、批間一致性以及酵素和標記化學相關的智慧財產權決定著實驗室的採用率和性能。

學術界、臨床實驗室、受託研究機構和產業界的相關人員依賴穩定可靠的高純度試劑供應，以支持那些對可重複性和合規性要求極高的實驗。同時，定序平台的激增催生了多個平行的試劑生態系統，每個生態系統都有其獨特的驗證需求和支援服務。因此，買家在評估供應商時，不僅會考慮價格和供貨情況，還會關注技術支援、驗證數據以及與資訊學工作流程的整合。

綜上所述，這些動態凸顯了深入了解產品類型、特定應用需求和平台依賴的必要性。決策者面臨的緊迫挑戰是如何使採購和產品開發策略與現代定序工作流程的實際操作相契合，同時預見技術和政策方面的潛在變革。

技術進步、平台生態系統整合和供應鏈韌性如何重新定義試劑供應商的角色和產品策略

定序試劑市場正受到多種變革性因素的重塑，這些因素提高了對供應商應對力和產品特異性的要求。下一代和第三代測序技術的進步，對試劑提出了更高的要求，即需要能夠支援更高保真度的合成、更寬的動態範圍，並與日益自動化的文庫製備流程相容。同時，RNA定序和總體基因體學應用的擴展，也推動了對低起始量樣本、分解核酸和複雜環境基質最佳化的試劑的需求。

隨著技術變革的推進，平台供應商正透過提供垂直整合的試劑組和認證項目，加深對生態系統的控制。這些項目雖然簡化了終端用戶的驗證流程，但也為第三方供應商設置了障礙。這一趨勢影響著新舊試劑參與企業，迫使新參與企業在與平台建立緊密夥伴關係和採取更廣泛的跨平台相容策略之間做出選擇。疫情期間的衝擊暴露了依賴單一來源的關鍵酵素和高純度緩衝液的脆弱性，促使人們開始採用雙重採購和區域庫存策略。

最後，監管監督和實驗室認證要求與商業性壓力融合，推動了試劑可追溯性和品質系統文件編制標準的提高。總而言之，這些變化正在將試劑供應商轉變為策略合作夥伴，除了耗材之外，他們還提供技術服務、檢驗的工作流程和可靠的物流保障。

評估近期美國關稅措施對試劑採購、供應鏈設計和供應商本地化策略的累積影響

美國新推出的進口關稅為定序試劑生產商、經銷商和終端用戶帶來了複雜的商業環境。關稅調整會改變依賴進口原料、專用酵素和成品試劑套件的試劑生產商的成本結構，進而影響營運預算緊張的實驗室的採購決策。在許多情況下，最直接的影響是重新評估籌資策略，尋找替代供應商，調整採購時間，或重組定價模式以應對成本上漲。

除了直接的成本壓力外，關稅還會促使企業採取更長期的結構性因應措施。供應商可能會加快關鍵零件的本地化進程，在關稅更容易徵收的地區尋求免收費用生產安排，或重新設計產品包裝或零件以改變關稅分類。此類調整通常涉及加強供應鏈文件的審核、最佳化關稅編碼，以及與海關當局溝通，在適用情況下尋求豁免和申訴。

實驗室和採購機構正在透過擴展供應商風險評估標準和合格通訊協定來應對這一變化，將總到岸成本分析納入考量，從而降低關稅的影響。一些機構可能還會優先選擇物流更方便或保存期限更長的物流，以減少短期中斷的影響。整體而言，關稅主導的動態提升了供應商透明度、合約靈活性以及跨境運輸可追溯性和合規性證明能力的重要性。

主導細分的關鍵洞察揭示了產品類型、應用需求、技術選擇、終端用戶期望和平台生態系統如何決定試劑策略。

對細分市場的細緻分析揭示了不同產品類型、應用、技術、最終用戶和平台的需求促進因素和要求。在各類產品中，適配器和標籤、緩衝液和溶液、標記試劑、核苷酸以及聚合酵素和酵素的品質規格和驗證需求各不相同。特別是聚合酵素和酶，包括DNA聚合酵素、連接酶和逆轉錄酶，它們各自具有獨特的穩定性特徵和儲存條件，這會影響物流和使用者操作流程。這些差異會影響庫存計劃和客戶支援模式，因為依賴酵素的工作流程通常需要低溫運輸完整性和清晰的操作說明，以確保實驗成功。

應用領域進一步影響試劑的選擇標準。總體基因體學定序強調污染控制和能夠適應不同樣本基質的穩健萃取化學方法，而RNA定序則重視能夠保護不穩定轉錄物並最大限度減少分解的試劑。標靶定序流程優先考慮能夠實現多重定序的高特異性標記和接頭系統，而全基因組定序則要求試劑能夠在各種文庫中實現均勻覆蓋和最小偏差。這些應用層面的要求促使人們需要技術文件、檢驗的通訊協定以及（如適用）臨床或監管部門的批准。

技術細分凸顯了相容性方面的考量。新一代定序平台通常傾向於使用短讀長定序化學試劑和針對高性能自動化最佳化的試劑組；桑格定序憑藉其成熟的試劑操作流程，在標靶驗證領域佔據一席之地；而第三代定序則需要針對長讀長和單分子保真度客製化的化學試劑。最終用戶群體（包括學術研究機構、受託研究機構、醫療保健和診斷實驗室以及製藥和生物技術公司）的細分，使得他們對規模、文件和周轉時間有著不同的期望。學術實驗室可能優先考慮成本和靈活性，而診斷實驗室則要求批次間性能可重複性以及符合監管要求的可追溯性。

平台特定的生態系統增加了複雜性。主要的儀器系列包括 Illumina、Oxford Nanopore、PacBio 和 Thermo Fisher，每個系列都支援平台特定的耗材和輔助設備。在這些系列中，子平台，例如 Illumina 的 MiSeq、NextSeq 和 NovaSeq；Oxford Nanopore 的 MinION 和 PromethION；PacBio 的 RS II 和 Sequel；以及 Thermo Fisher 的 Ion Torrent 和 QuantStudio，都需要特定的試劑規格、驗證步驟和使用者培訓。供應商如果能夠將產品開發和驗證與平台 API 和服務網路相匹配，就可以縮短客戶的資格確認週期，並在平台封閉的環境中提高產品的採用率。

美洲、歐洲、中東和非洲以及亞太地區的區域動態和採購行為將影響供應商的定位和營運重點。

美洲、歐洲、中東和非洲以及亞太地區的區域動態正在影響採購行為、監管預期和供應鏈架構。美洲擁有高度集中的研究機構、生物技術中心和臨床實驗室，支撐著一個成熟的試劑市場，該市場重視快速交貨、技術支援以及與高性能自動化系統的整合。臨床環境中的法律規範和認證流程獎勵供應商透過提供詳細的文件、品管證據和檢驗的工作流程來加快產品應用。

歐洲、中東和非洲醫療基礎設施和研發能力的差異導致採購方的優先事項各不相同。西方市場通常優先考慮監管合規性、供應商認證和永續性，而新興市場則優先考慮價格和物流便利性。此外，歐洲、中東和非洲複雜的跨境供應法規和關稅制度也會影響交貨前置作業時間和庫存計畫。

亞太地區定序儀的快速部署與強大的試劑和組件生產基地相結合。亞太地區的實驗室通常尋求本地化的配方專業知識、快速的技術響應和具有競爭力的價格，而區域製造商和契約製造製造商則提供了近岸外包和經濟高效的採購機會。所有地區的優先事項都是可預測的供應、符合當地法規和進口要求，以及供應商提供針對當地應用情境的技術培訓和應用支援的能力。

領先的試劑供應商如何利用創新、平台夥伴關係和供應鏈韌性來加強其市場地位和客戶價值提案

領先的試劑供應商透過技術創新、與平台供應商的策略夥伴關係以及超越產品交付的增強型服務來實現差異化。對專有酶工程、穩定化化學和標記技術的投資使供應商能夠彌補性能差距，並支援低起始量RNA測序和複雜元基因組文庫等新興應用。同時，與儀器製造商的合作以及參與檢驗專案有助於供應商獲得首選供應商地位，並簡化客戶採用流程。

除了產品研發之外，企業還透過多元化製造地、確保替代原料供應以及實施更嚴格的品管系統來增強供應鏈的韌性。這些營運措施降低了中斷風險，並有助於履行有關供貨的合約承諾。客戶的能力也不斷提升，許多供應商提供技術培訓、工作流程最佳化服務以及客製化試劑組，這些試劑盒包含試劑、經過檢驗的方案和數據分析指導。

競爭動態有利於那些能夠將雄厚的科學知識、透明的監管文件和靈活的物流模式結合的企業。策略併購和聯盟仍然是獲取互補技術、拓展產品系列以及加速進入新的應用領域和地理的有效途徑。對於採購者而言，這意味著其關注點將從單純的單價轉向評估供應商在研發、製造和售後支援等方面的能力。

為試劑生產商和採購負責人提供切實可行的建議，以提高韌性、加快驗證速度並透過技術服務產品實現差異化。

為了因應不斷變化的技術需求和地緣政治壓力，產業領導者應優先採取一系列切實有效、影響深遠的行動，將科學研究績效與營運韌性結合。首先，建立多源資訊來源框架，對關鍵酵素和緩衝液的替代生產商進行資格認證，並透過標準化的檢驗通訊協定證明其等效性。這可以降低單一供應商失效的風險，並在合約談判中增強談判籌碼。

第二，增加與平台供應商和臨床實驗室的技術合作力度，共同開發經過驗證的試劑組和認證途徑，以縮短推廣週期。此類合作可包括交叉檢驗測試，以確保不同儀器型號間結果的可重複性；聯合品牌培訓材料；以及聯合技術支援。第三，最佳化供應鏈設計，例如在地化庫存時效性試劑、實施冗餘低溫運輸以及採用精通關稅的物流策略，以降低進口成本波動。

第四，我們透過採用國際認可的品管標準、加強原料可追溯性以及全面管理穩定性數據和批次放行數據，來強化監管和品質文件記錄。第五，我們優先提供以客戶為中心的服務，例如承包文庫製備試劑套件、易於自動化的格式以及按需技術支持，並在價格之外提供差異化服務。這些措施共同幫助機構保持營運連續性，維護實驗室工作流程中的科學誠信，並在不斷變化的市場環境中保持競爭優勢。

一種結合主要相關人員訪談、技術文獻綜述和供應鏈圖譜的調查方法，旨在獲得關於試劑市場的有效且可操作的見解。

本分析的調查方法結合了主要相關人員訪談、技術文獻綜述和供應鏈圖譜分析，以確保得出可靠且有理有據的結論。主要研究包括對實驗室主任、採購負責人、平台專家和試劑研發科學家進行結構化訪談，以了解試劑性能、驗證困難和採購限制等方面的實際需求。此外，也諮詢了資訊學和品質保證專家，以了解文件和監管方面的要求。

二手研究透過同行評審的出版物、驗證研究和製造商文檔，證實了定序化學和平台要求的技術趨勢。供應鏈圖譜識別了原料採購、製造外包關係和低溫運輸依賴性中的關鍵節點，為風險評估和緩解策略提供了基礎。整個研究過程中採用了數據三角測量和交叉檢驗，以協調不同相關人員群體的觀點，並揭示供應商行為和買方期望中的一致模式。

調查方法包括不同機構間實驗室層級的差異以及平台特異性試劑生態系的演化。在主要研究中，我們遵守了倫理考量和保密措施，並保持了方法學的透明度，以便在可行的情況下重複關鍵分析步驟。

戰略要務綜合分析表明，試劑品質、平台驗證和供應鏈敏捷性如何共同決定營運韌性和推廣軌跡。

綜合證據表明，試劑生態系統正變得日益專業化、服務化，並且對技術和政策的變動更為敏感。能夠提供高品質、平台驗證的試劑，同時提供強大的檢驗支援和穩健的供應鏈的研究公司，更有能力滿足科學研究、臨床和工業終端用戶的多樣化需求。平台特定的生態系統和應用主導的需求正迫使試劑供應商採取差異化的產品策略，並投資於認證和文件能力建設，以解決監管和可重複性方面的問題。

同時，地緣政治發展和關稅調整凸顯了供應鏈敏捷性和關稅敏感型物流的重要性，促使供應商和實驗室重新思考籌資策略和庫存管理。最終結果是，市場環境要求科學研究卓越性必須與營運可靠性和商業性彈性相符。價值鏈上相關人員的首要任務是將技術訣竅轉化為可複製、檢驗的解決方案，以便無論區域或政策相關干擾如何，都能可靠地大規模部署。

展望未來，平台創新、應用多樣化和供應鏈韌性之間的相互作用可能會塑造定序試劑領域的競爭動態和採用模式。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 腫瘤學研究中對單細胞定序試劑日益成長的需求推動了試劑創新。
  • 採用長讀長定序技術來改善基因組組裝和結構變異檢測
  • 加速開發用於法醫學和臨床應用的低投入量和分解樣品試劑
  • 在定序工作流程中更充分地整合自動化技術，以實現試劑標準化並提高通量。
  • 可攜式孔測序試劑的研發，旨在實現現場病原體檢測和環境監測。
  • 結合表觀表觀基因和轉錄組學分析的多組體學定序試劑套件在生物標記發現的應用日益廣泛
  • 經濟高效的條碼和多重標記試劑的出現，促進了大規模人群基因組學研究。
  • 針對罕見疾病診斷的標靶定序技術的創新提高了試劑的特異性和效率
  • 開發無需逆轉錄即可進行全面轉錄組分析的直接RNA定序試劑

第6章美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

第8章 依產品類型分類的定序試劑市場

  • 適配器和標籤
  • 緩衝液和溶液
  • 標記試劑
  • 核苷酸
  • 聚合酵素和酶
    • DNA聚合酵素
    • 連接酶
    • 逆轉錄酶

第9章 依應用分類的定序試劑市場

  • 總體基因體學體定序
  • RNA定序
  • 目標序列
  • 全基因組序列分析

第10章 依技術分類的定序試劑市場

  • 下一代定序
  • 桑格定序
  • 第三代定序

第11章 依最終用戶分類的定序試劑市場

  • 學術研究
  • 合約研究組織
  • 醫療保健和診斷實驗室
  • 製藥和生物技術公司

第12章 定序試劑市場（依平台分類）

  • Illumina
    • Miseq
    • Nextseq
    • Novaseq
  • Oxford Nanopore
    • Minion
    • Promethion
  • Pacbio
    • Rs Ii
    • Sequel
  • Thermo Fisher
    • Ion Torrent
    • Quantstudio

第13章 各地區定序試劑市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 定序試劑市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國定序試劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Illumina, Inc.
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • QIAGEN NV
    • MGI Tech Co. Ltd.
    • Pacific Biosciences of California, Inc.
    • Oxford Nanopore Technologies plc
    • Takara Bio Inc.
    • New England Biolabs, Inc.
Product Code: MRR-A26E0E57453C

The Sequencing Reagents Market is projected to grow by USD 12.80 billion at a CAGR of 10.93% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 5.58 billion
Estimated Year [2025] USD 6.20 billion
Forecast Year [2032] USD 12.80 billion
CAGR (%) 10.93%

A concise orientation to the sequencing reagents landscape highlighting technological differentiation, procurement realities, and platform-driven supplier dynamics

The sequencing reagents sector occupies a critical junction between molecular biology innovation and downstream applications that power diagnostics, therapeutics discovery, and environmental genomics. Technological advances in read length, throughput, and chemistry have shifted reagent requirements from general-purpose components to highly specialized, platform-optimized formulations. This evolution has produced a dynamic supplier landscape where reagent quality, lot-to-lot consistency, and intellectual property around enzymes and labeling chemistries determine adoption and performance across laboratories.

Stakeholders across academia, clinical laboratories, contract research organizations, and industry rely on a predictable supply of high-purity reagents to support experiments that demand reproducibility and regulatory compliance. At the same time, the proliferation of sequencing platforms has created parallel reagent ecosystems, each with distinct validation needs and support services. As a result, buyers now evaluate vendors not only on price and availability but also on technical support, validation data, and integration with informatics workflows.

Taken together, these dynamics underscore the need for a nuanced understanding of product categories, application-specific demands, and platform dependencies. For decision-makers, the immediate imperative is to align procurement and product development strategies with the operational realities of modern sequencing workflows while anticipating both technological and policy-driven disruptions.

How technological advances, platform ecosystem consolidation, and supply chain resilience imperatives are redefining reagent supplier roles and product strategies

The sequencing reagents landscape is being reshaped by several transformative forces that collectively raise the bar for supplier responsiveness and product specificity. Advances in next-generation and third-generation chemistries are demanding reagents that can support higher-fidelity synthesis, broader dynamic range, and compatibility with increasingly automated library-preparation workflows. Concurrently, the expansion of RNA sequencing and metagenomics applications has increased demand for reagents optimized for low-input samples, degraded nucleic acids, and complex environmental matrices.

Parallel to these technical shifts, platform vendors are deepening their ecosystem control by offering vertically integrated reagent kits and certification programs that simplify validation for end users while creating barriers for third-party suppliers. This trend has implications for new entrants and established reagent companies alike, who must decide between tight platform partnerships or broader cross-platform compatibility strategies. Supply chain resilience has become another defining variable; the pandemic-era disruptions exposed vulnerabilities in single-source dependencies for critical enzymes and high-purity buffers, prompting a wave of dual-sourcing and regional inventory strategies.

Finally, regulatory scrutiny and laboratory accreditation requirements are converging with commercial pressures to drive higher documentation standards around reagent traceability and quality systems. Collectively, these shifts are transforming reagent suppliers into strategic partners that offer technical service, validated workflows, and logistical reliability in addition to consumable products.

Assessing the cumulative effects of recent United States tariff actions on reagent sourcing, supply chain design, and supplier localization strategies

The introduction of new tariff measures affecting imports into the United States has created a complex operating environment for manufacturers, distributors, and end users of sequencing reagents. Tariff adjustments alter the cost structure for reagent producers that rely on imported raw materials, specialized enzymes, or finished kits, and they can influence procurement decisions across laboratories that face tighter operational budgets. In many cases, the immediate effect is a re-evaluation of sourcing strategies to identify alternative suppliers, shift purchasing timing, or absorb incremental costs through restructured price models.

Beyond direct cost pressures, tariffs can drive longer-term structural responses. Suppliers may accelerate efforts to localize production of critical components, pursue toll manufacturing arrangements within tariff-friendly jurisdictions, or redesign product packaging and components to alter customs classifications. These adaptations are often accompanied by increased diligence around supply chain documentation, tariff code optimization, and engagement with customs authorities to pursue exclusions or appeals where applicable.

Laboratories and procurement organizations respond by expanding qualification protocols to include supplier risk metrics and total landed cost analyses that factor in tariff exposure. Some institutions may prioritize reagents with simplified logistics or enhanced shelf life to buffer short-term disruptions. In the aggregate, tariff-driven dynamics increase the value of supplier transparency, contractual flexibility, and the capacity to demonstrate traceability and compliance across cross-border shipments.

Key segmentation-driven insights revealing how product categories, application demands, technology choices, end-user expectations, and platform ecosystems dictate reagent strategy

A granular view of segmentation reveals differentiated demand drivers and requirements across product types, applications, technologies, end users, and platforms. Within product type, adapters and tags, buffers and solutions, labeling reagents, nucleotides, and polymerases and enzymes each exhibit distinct quality specifications and validation needs; polymerases and enzymes in particular encompass DNA polymerases, ligases, and reverse transcriptases, each carrying unique stability profiles and storage conditions that affect logistics and user protocols. These distinctions inform inventory planning and customer support models because enzyme-dependent workflows often require cold-chain integrity and clear handling instructions to ensure experimental success.

Application domains further shape reagent selection criteria. Metagenomics sequencing places premium value on contamination controls and robust extraction chemistries capable of addressing diverse sample matrices, while RNA sequencing emphasizes reagents that preserve labile transcripts and minimize degradation. Targeted sequencing workflows prioritize high-specificity labeling and adapter systems that enable multiplexing, and whole genome sequencing demands reagents that support uniform coverage and minimal bias across extensive libraries. These application-level requirements drive demand for technical documentation, validated protocols, and certification for clinical or regulatory use where applicable.

Technology segmentation underscores compatibility considerations. Next-generation sequencing platforms often favor reagent kits optimized for short-read chemistries and high-throughput automation, Sanger sequencing retains a niche for targeted validation with long-established reagent conventions, and third-generation sequencing requires chemistries tailored for long reads and single-molecule fidelity. End-user segmentation-spanning academic research, contract research organizations, healthcare and diagnostic laboratories, and pharmaceutical and biotechnology companies-creates varying expectations for scale, documentation, and turnaround times; academic labs may prioritize cost and flexibility, whereas diagnostics labs demand reproducible lot-to-lot performance and regulatory-grade traceability.

Platform-specific ecosystems introduce another layer of complexity. Major instrument families include Illumina, Oxford Nanopore, PacBio, and Thermo Fisher, each supported by platform-tailored consumables and accessory instruments. Within those families, sub-platforms such as Illumina's MiSeq, NextSeq, and NovaSeq; Oxford Nanopore's MinION and PromethION; PacBio's RS II and Sequel; and Thermo Fisher's Ion Torrent and QuantStudio require specific reagent formats, validation steps, and user training. Suppliers that align product development and validation with platform APIs and service networks can shorten customer qualification cycles and increase adoption in platform-locked environments.

Regional dynamics and procurement behaviors across the Americas, Europe Middle East and Africa, and Asia-Pacific that drive supplier positioning and operational priorities

Regional dynamics shape procurement behaviors, regulatory expectations, and supply chain architectures across the Americas, Europe Middle East and Africa, and Asia-Pacific. In the Americas, a concentration of research institutions, biotech hubs, and clinical laboratories supports a sophisticated reagent market that values rapid delivery, technical support, and integration with high-throughput automation. Regulatory frameworks and accreditation processes in clinical settings further incentivize suppliers to provide detailed documentation, quality management evidence, and validated workflows to facilitate adoption.

Across Europe, the Middle East and Africa, heterogeneity in healthcare infrastructure and research capacity results in divergent buyer priorities. Western European markets typically emphasize regulatory conformity, supplier certifications, and sustainability considerations, whereas emerging markets focus on affordability and logistical accessibility. The broader EMEA region also exhibits complex cross-border supply considerations and customs regimes that affect lead times and inventory planning.

The Asia-Pacific region combines rapidly expanding sequencing adoption with a strong manufacturing base for reagents and components. Laboratories in APAC often seek local-formulation expertise, rapid technical response, and competitive pricing, while regional manufacturers and contract producers offer opportunities for nearshoring and cost-effective sourcing. Across all regions, the shared priorities are predictable supply, compliance with local regulatory and import requirements, and the ability of suppliers to provide technical training and application support tailored to regional use cases.

How top reagent suppliers are leveraging innovation, platform partnerships, and supply chain resilience to strengthen market position and customer value propositions

Leading reagent suppliers are differentiating through a combination of technical innovation, strategic partnerships with platform vendors, and enhanced service offerings that go beyond product delivery. Investments in proprietary enzyme engineering, stabilization chemistries, and labeling technologies enable suppliers to address performance gaps and support emerging applications such as low-input RNA sequencing and complex metagenomic libraries. At the same time, collaboration with instrument manufacturers and participation in validation programs creates pathways for preferred supplier status and streamlined customer onboarding.

Beyond product R&D, companies are strengthening supply chain resilience by diversifying manufacturing footprints, qualifying alternate raw material sources, and implementing stricter quality control regimes. These operational measures reduce the risk of disruption and support contractual commitments for availability. Customer-facing capabilities are also expanding, with many suppliers offering technical training, workflow optimization services, and customized reagent kits that bundle reagents with validated protocols and data analysis guidance.

Competitive dynamics favor organizations that can combine robust scientific IP with transparent regulatory documentation and responsive logistical models. Strategic M&A and alliances continue to be tools for accessing complementary technologies, broadening product portfolios, and accelerating entrance into new application areas or geographic regions. For buyers, these trends mean an increased emphasis on evaluating supplier capability across R&D, manufacturing, and post-sale support rather than focusing solely on unit pricing.

Actionable recommendations enabling reagent manufacturers and procurement leaders to enhance resilience, accelerate validation, and differentiate through technical service offerings

To navigate a landscape of evolving technological requirements and geopolitical pressures, industry leaders should prioritize a set of pragmatic, high-impact actions that align operational resilience with scientific performance. First, establish multi-source procurement frameworks that qualify alternative manufacturers for critical enzymes and buffers while documenting equivalency through standardized validation protocols. This reduces exposure to single-source disruptions and provides leverage during contract negotiations.

Second, invest in close technical partnerships with platform vendors and clinical laboratories to co-develop validated reagent kits and certification pathways that shorten adoption cycles. Such collaborations can include cross-validation studies, co-branded training materials, and joint technical support to ensure reproducible outcomes across instrument generations. Third, optimize supply chain design by localizing inventory for time-sensitive reagents, implementing cold-chain redundancies, and employing tariff-savvy logistics strategies to mitigate import-related cost volatility.

Fourth, strengthen regulatory and quality documentation by adopting internationally recognized quality management standards, enhancing traceability of raw materials, and maintaining thorough stability and lot-release data. Fifth, prioritize customer-centric services such as turnkey library preparation kits, automation-friendly formats, and on-demand technical assistance to differentiate offerings beyond price. Collectively, these actions will help organizations maintain operational continuity, preserve scientific integrity in laboratory workflows, and sustain competitive advantage amid shifting market conditions.

Methodological framework combining primary stakeholder interviews, technical literature synthesis, and supply chain mapping to produce validated and actionable reagent market insights

The research methodology underpinning this analysis combined primary stakeholder engagements, technical literature synthesis, and supply chain mapping to ensure robust and defensible insights. Primary research included structured interviews with laboratory directors, procurement leads, platform specialists, and reagent development scientists to capture real-world priorities around reagent performance, validation hurdles, and sourcing constraints. These conversations were supplemented by expert consultations with informatics and quality assurance professionals to understand documentation and regulatory expectations.

Secondary research drew on peer-reviewed publications, validation studies, and manufacturer documentation to corroborate technical trends in sequencing chemistry and platform requirements. Supply chain mapping identified critical nodes for raw material procurement, contract manufacturing relationships, and cold-chain dependencies, which informed risk assessments and mitigation strategies. Data triangulation and cross-validation were employed throughout to reconcile perspectives from different stakeholder groups and to surface consistent patterns in supplier behavior and buyer expectations.

Limitations of the methodology include variability in lab-level practices across institutions and the evolving nature of platform-specific reagent ecosystems, which means some operational nuances may shift as new chemistries and instrument versions are introduced. Ethical considerations and confidentiality safeguards were observed during primary engagements, and methodological transparency was maintained to allow replication of key analytical steps where feasible.

Synthesis of strategic imperatives showing how reagent quality, platform validation, and supply chain agility jointly determine operational resilience and adoption trajectories

The collective evidence points to a reagent ecosystem that is increasingly specialized, service-oriented, and sensitive to both technological and policy-driven disruptions. Suppliers that can deliver high-quality, platform-validated reagents while offering robust technical support and resilient supply chains will be better positioned to meet the diverse needs of research, clinical, and industrial end users. Platform-specific ecosystems and application-driven requirements are compelling reagent providers to adopt differentiated product strategies and to invest in certification and documentation capabilities that address regulatory and reproducibility concerns.

At the same time, geopolitical developments and tariff realignments have elevated the importance of supply chain agility and tariff-aware logistics, prompting both suppliers and laboratories to reassess sourcing strategies and inventory management. The net effect is a market environment where scientific excellence must be matched by operational reliability and commercial flexibility. For stakeholders across the value chain, the priority is to convert technical know-how into reproducible, validated solutions that can be reliably deployed at scale, regardless of regional or policy-related disruptions.

Looking forward, the interplay between platform innovation, application diversification, and supply chain resilience will continue to shape competitive dynamics and adoption patterns within the sequencing reagents domain.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expanding demand for single-cell sequencing reagents in oncology research driving reagent innovation
  • 5.2. Adoption of long-read sequencing chemistry for improved genome assembly and structural variant detection
  • 5.3. Accelerating development of low-input and degraded sample reagents for forensic and clinical applications
  • 5.4. Increased integration of automation in sequencing workflows boosting reagent standardization and throughput
  • 5.5. Growth of portable nanopore sequencing reagents enabling field-based pathogen detection and environmental monitoring
  • 5.6. Rising adoption of multiomic sequencing kits combining epigenomic and transcriptomic analyses in biomarker discovery
  • 5.7. Emergence of cost-effective barcoding and multiplexing reagents to facilitate large-scale population genomics studies
  • 5.8. Innovation in targeted sequencing panels for rare disease diagnostics enhancing reagent specificity and efficiency
  • 5.9. Development of direct RNA sequencing reagents for comprehensive transcriptome profiling without reverse transcription

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Sequencing Reagents Market, by Product Type

  • 8.1. Adapters And Tags
  • 8.2. Buffers And Solutions
  • 8.3. Labeling Reagents
  • 8.4. Nucleotides
  • 8.5. Polymerases And Enzymes
    • 8.5.1. Dna Polymerases
    • 8.5.2. Ligases
    • 8.5.3. Reverse Transcriptases

9. Sequencing Reagents Market, by Application

  • 9.1. Metagenomics Sequencing
  • 9.2. Rna Sequencing
  • 9.3. Targeted Sequencing
  • 9.4. Whole Genome Sequencing

10. Sequencing Reagents Market, by Technology

  • 10.1. Next-Generation Sequencing
  • 10.2. Sanger Sequencing
  • 10.3. Third-Generation Sequencing

11. Sequencing Reagents Market, by End User

  • 11.1. Academic Research
  • 11.2. Contract Research Organizations
  • 11.3. Healthcare And Diagnostic Laboratories
  • 11.4. Pharmaceutical And Biotechnology Companies

12. Sequencing Reagents Market, by Platform

  • 12.1. Illumina
    • 12.1.1. Miseq
    • 12.1.2. Nextseq
    • 12.1.3. Novaseq
  • 12.2. Oxford Nanopore
    • 12.2.1. Minion
    • 12.2.2. Promethion
  • 12.3. Pacbio
    • 12.3.1. Rs Ii
    • 12.3.2. Sequel
  • 12.4. Thermo Fisher
    • 12.4.1. Ion Torrent
    • 12.4.2. Quantstudio

13. Sequencing Reagents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Sequencing Reagents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Sequencing Reagents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Illumina, Inc.
    • 16.3.2. Thermo Fisher Scientific Inc.
    • 16.3.3. F. Hoffmann-La Roche Ltd.
    • 16.3.4. Danaher Corporation
    • 16.3.5. QIAGEN N.V.
    • 16.3.6. MGI Tech Co. Ltd.
    • 16.3.7. Pacific Biosciences of California, Inc.
    • 16.3.8. Oxford Nanopore Technologies plc
    • 16.3.9. Takara Bio Inc.
    • 16.3.10. New England Biolabs, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SEQUENCING REAGENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SEQUENCING REAGENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SEQUENCING REAGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SEQUENCING REAGENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ADAPTERS AND TAGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LABELING REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NUCLEOTIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY DNA POLYMERASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY LIGASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REVERSE TRANSCRIPTASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY METAGENOMICS SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TARGETED SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SANGER SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THIRD-GENERATION SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY HEALTHCARE AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MISEQ, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NEXTSEQ, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY NOVASEQ, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY MINION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PROMETHION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY RS II, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY SEQUEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY ION TORRENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY QUANTSTUDIO, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SEQUENCING REAGENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 289. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 290. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PLATFORM, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY ILLUMINA, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY OXFORD NANOPORE, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY PACBIO, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA SEQUENCING REAGENTS MARKET SIZE, BY THERMO FISHER, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY POLYMERASES AND ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE SEQUENCING REAGENTS MARKET SIZE, BY PLAT